• Login
    • Join
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Manufacturing
    • Markets
    • Top 10
    • Buyers' Guide
    • Events
    • Microsites
    • More
  • Magazine
  • News
  • Exclusives
  • Manufacturing
  • Markets
  • Top 10
  • Buyers' Guide
  • Events
  • Microsites
  • Current & Past Issues
    Features
    Departments
    Columns
    Editorial
    Digital Edition
    Subscribe Now
    Advertise Now
    Editorial Guidelines
    eNewsletter Archive
    eBook
    Top Features
    Metallic Make Up for Orthopedic Materials

    Infection Control Strategies Offer a Plan of Pathogen Attack

    Multi-Dimensional Approaches to Orthopedic Implant Manufacturing

    Orthopedic Implants Are Fit to Print

    Fitting the Mold of Ortho Device Manufacturing
    Breaking News
    Certifications
    Clinical Trials
    Device Approvals & Patents
    Financial & Deals
    International
    Market Data & Trends
    OEM News
    Orthopedic Innovators
    People
    Product & Service Releases
    Products
    Quality, Recalls & Risk
    Regulatory & Legal
    Supplier & Contract Mfg.
    Live From Shows
    Top News & Features
    Orthobiologics Market to Top $10.3 Billion by 2030

    Artelon Granted U.S. FDA 510(k) Clearance for FlexBand, FlexPatch & FlexBand Plus

    Synergy Spine Solutions Completes Enrollment in IDE Clinical Trial

    Biocomposites Acquires Artoss, Maker of NanoBone Bone Graft Substitute

    Nevro Names Stryker Exec Greg Siller as Chief Commercial Officer
    3-D Printing/Additive Mfg.
    Assembly & Automation
    Biocompatibility & Testing
    Clean Room
    Coatings/Surface Modification
    Contract Manufacturing
    Design
    Extrusion
    Finishing
    Forging & Casting
    Instruments, Cases & Trays
    International/Offshoring
    Laser Processing
    Materials
    Machining & Tooling
    Molding
    Packaging & Sterilization
    Prototyping
    Research & Developement
    Software & Quality
    Staffing, Training & Prof. Dev.
    Supply Chain

    Former BD, J&J Executives Join Acuitive Technologies Board

    Augmedics Debuts New Features, Indications for xvision Platform

    Artelon Closes $20M Series B Funding

    Orthofix Unveils Seven-Year Outcome Data for M6-C Artificial Cervical Disc

    The Silicon Valley Bank Collapse and Its Impact on Compliance
    Biologics
    Bracing/Prosthetics
    Extremities
    Imaging
    Instruments
    Large Joint
    MIS/Robotics
    Spine/Neurology
    Trauma/Sports
    Top Markets
    3D Printing Provides Stepping Stones for New Orthopedic Footwear Innovations

    How Honeywell's Spectra Fiber is Used in Orthopedics, TAVR, and More

    All About Reverse Shoulder Devices: Analyzing the Factors Driving Their Popularity

    Evolution of the Global Orthopedic Biomaterials Market

    Industry Innovation: A Look at Regenerative Medicine in Orthopedics
    Companies
    Categories
    Company Capabilities
    White Papers
    Add New Company
    International Buyers Guide Companies
    Tiodize

    Braxton Manufacturing

    Life Science Outsourcing Inc.

    Modern Plastics

    AV&R
    Industry Events
    Webinars
    • Magazine
      • Current & Past Issues
      • Features
      • Editorial
      • Departments
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • eBook
    • Breaking News
    • Buyers' Guide
      • Companies
      • Categories
      • Company Capabilities
      • White Papers
      • Add Your Company
    • Manufacturing
      • 3-D Printing/Additive Mfg.
      • Assembly & Automation
      • Biocompatibility & Testing
      • Clean Room
      • Coatings/Surface Modification
      • Contract Manufacturing
      • Design
      • Extrusion
      • Finishing
      • Forging & Casting
      • Instruments, Cases & Trays
      • International/Offshoring
      • Laser Processing
      • Materials
      • Machining & Tooling
      • Molding
      • Packaging & Sterilization
      • Prototyping
      • Research & Developement
      • Software & Quality
      • Staffing, Training & Prof. Dev.
      • Supply Chain
    • Markets
      • Biologics
      • Bracing/Prosthetics
      • Extremities
      • Imaging
      • Instruments
      • Large Joint
      • MIS/Robotics
      • Spine/Neurology
      • Trauma/Sports
    • Top 10
    • Online Exclusives
    • Slideshows
    • Videos
    • Webinars
    • Events
      • Industry Events
    • Live from Show Event
    • About Us
      • About Us
      • Contact Us
      • Privacy Policy
      • Terms of Use
      • Advertise With Us
    Columns

    Disinfectant Efficacy Testing: How Limiting Bioburden Keeps You Compliant

    Medical devices are only effective if they can perform their intended functions safely, and safe performance starts with reducing bioburden.

    Disinfectant Efficacy Testing: How Limiting Bioburden Keeps You Compliant
    Leslie Tavares, Melinda Johnson and Jessica Lawrence, WuXi AppTec09.14.21
    Disinfectant efficacy testing (DET) is a crucial component of any medical device manufacturing operation. Medical devices are only effective if they can perform their intended functions safely, and safe performance starts with reducing bioburden.

    DET is a quality control measure that helps organizations validate the efficacy of their cleaning processes. It is designed to challenge a facility’s cleaning regimen to ensure that bacterial and fungal pathogens are being reduced to acceptable levels.

    The process requires analyzing 2-inch by 2-inch material slides (i.e., coupons) taken from surfaces within facilities to understand the organisms present and validate that, if effective, the disinfectants and protocols in place promote a safe environment. Consistent environmental monitoring is essential for facilities that experience dramatic seasonal changes—new seasons mean new pathogens and new transfer methods.

    Regular environmental monitoring is not only recommended, the U.S. Food and Drug Administration (FDA) mandates it. Regulatory bodies frequently audit facilities to ensure they have evidence of adequate controls over their environmental conditions and to ensure proper conditions for operations. Facilities that have recently expanded, changed locations, or switched to new disinfectant products are particularly susceptible to non-compliance.

    There is no way to achieve 100 percent sterilization. If organizations are seeing frequent excursions, reevaluation of the entire cleaning process may be necessary. Still, DET can validate that facilities are using the right amounts of the right disinfectants for the proper periods of time to achieve the safest results.

    How DET Works
    DET starts with material coupons. Researchers inoculate the coupons with challenge organisms (i.e., bacteria, spores, fungus, etc.) and then subject them to a predetermined cleaning process. The test laboratory mimics the original facility’s wiping, mopping, spraying, and contact duration of the products used during real-world cleaning procedures. They then extract the coupons and measure the number of challenge organisms that remain.

    At this point, researchers measure log reduction, or how thoroughly a decontamination process reduces the population of each challenge organism utilized. The test objective is to achieve a two- or three-log reduction of pathogens after subjecting coupons to the disinfection process. A two-log reduction means the process removed 99 percent of pathogens; three-log means 99.9 percent are gone. Spores and fungi require a two-log reduction, while vegetative bacteria require a three-log reduction.

    Put simply, DET will determine if a facility’s cleaning regimen is killing problematic organisms in its environment. Between testing for organisms, utilizing facility-specific environmental isolates, running a neutralization validation, conducting efficacy checks, and allowing for a recovery step, the DET process can be complicated and time-intensive. When it comes to understanding current regulatory requirements and deciphering insights from previous testing, the advantages of partnering with an experienced laboratory partner become clear.

    How to Avoid DET Pitfalls
    Surface type, contact time, organisms present, disinfecting action, and hold times can all impact DET results. Any time one of these variables is altered, adjusted or overlooked, previous DET results may be affected or become invalid altogether. As combinations increase, DET studies become larger and more complex.

    It may be tempting for organizations to try to save time and money on DET by combining testing for various locations. However, this approach is fundamentally flawed. Each site will have its unique variables that will impact DET and applying results haphazardly can lead to regulatory non-compliance. A more efficient and accurate approach is to send coupons and organisms from each location and, if necessary, prioritize the most critical ones. Then, after the initial round of testing, proceed with the following location and so on.

    If a manufacturer has discovered a new or unexpected organism during testing, they can have it identified and held for later testing. Legacy knowledge of a particular facility is another instance in which a lab partner can be helpful. An external lab will often have the capacity to deal with new organisms and the ability to run tests on them in the future. Either way, organizations need to make sure someone is consistently monitoring organisms within the local environment to limit surprise variables during subsequent DET efforts.

    A facility that does not achieve the log reduction it needs for certain combinations may need to alter its cleaning regimen. When sanitizer is left in contact with surfaces for too long, it can degrade and decline in efficacy. Sometimes facilities also try to speed up the disinfectant process by reducing the specified contact time. But too short a contact time on a surface can also reduce a sanitizer’s efficacy. Other mitigating factors include the humidity and temperature of the facility. Drastic fluctuations in either can influence the type and number of organisms present and impact a disinfectant’s effectiveness in day-to-day use.

    Companies can also ensure successful DET results by being proactive, especially if they build new facilities or expand existing ones. Any change in infrastructure can bring new surfaces and new variables, so it is vital to arrange DET as soon as those variables are known. New facilities will not have the environmental monitoring data needed to identify the common pathogens found in their critical areas, but a laboratory testing partner should be able to use stock isolates and supplement with actual data using those site-specific isolates later.

    Advice for Organizations Undergoing DET
    It is essential to keep in mind that the main objective of DET is patient and staff safety—it is the goal of both medical device manufacturers and regulatory bodies alike. Therefore, the more thoroughly an organization prepares for DET, the greater the likelihood of successful testing and safe products. An experienced laboratory testing partner can help validate expanded or evolved cleaning processes and write new protocols that reflect emerging regulatory guidance.

    DET should be considered a valuable tool to help organizations ensure their disinfectant processes are as safe and effective as possible while also meeting regulatory standards. Whether disinfectant protocols are conducted in-house or validated by a laboratory testing partner, the same guiding principles should be followed: plan ahead, be methodical, follow appropriate testing protocols, and maintain consistency. These factors can be critical to successful testing, contribute to overall productivity and ensure patient and staff safety. 


    Leslie Tavares is a manager of the Microbial Solutions Lab and Custom Studies Group at WuXi AppTec. 

    Melinda Johnson and Jessica Lawrence are technical specialists with the Technical Services Group at WuXi AppTec. They regularly consult with customers on cleaning and disinfectant protocols.
      Loading, Please Wait..

      Trending
      • Treace To Buy RPM-3D Tech For Up To $30 Million
      • Nevro Names Stryker Exec Greg Siller As Chief Commercial Officer
      • FDA Approves Centinel Spine's Two-level Prodisc L Total Disc Replacement
      • Cementless Hip Implants Are Gradually Losing Their Popularity In Europe
      • Spineart, ECential Robotics Begin Partnership
      Breaking News
      • Orthobiologics Market to Top $10.3 Billion by 2030
      • Artelon Granted U.S. FDA 510(k) Clearance for FlexBand, FlexPatch & FlexBand Plus
      • Synergy Spine Solutions Completes Enrollment in IDE Clinical Trial
      • Biocomposites Acquires Artoss, Maker of NanoBone Bone Graft Substitute
      • Nevro Names Stryker Exec Greg Siller as Chief Commercial Officer
      View Breaking News >
      CURRENT ISSUE

      May/June 2023

      • Metallic Make Up for Orthopedic Materials
      • Infection Control Strategies Offer a Plan of Pathogen Attack
      • Multi-Dimensional Approaches to Orthopedic Implant Manufacturing
      • View More >

      Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
      You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

      • About Us
      • Privacy Policy
      • Terms And Conditions
      • Contact Us

      follow us

      Subscribe
      Nutraceuticals World

      Latest Breaking News From Nutraceuticals World

      Sempera Organics and Alchemist Labs Announce Partnership for Mushroom Testing
      Nektium Expands International Distribution Network for Botanical Extracts
      Kemin Receives Positive EFSA Opinion for BetaVia Pure, its Beta-Glucan Ingredient
      Coatings World

      Latest Breaking News From Coatings World

      Dunn-Edwards Announces 2024 Color + Design Trends to Watch
      Aramsco Acquires Pantheon Surface
      American Chemistry Council Recognizes Covestro for Sustainability Leadership
      Medical Product Outsourcing

      Latest Breaking News From Medical Product Outsourcing

      ISO 13485:2016 Certification Granted to Boston BioProducts
      Paul Colvin Joins Ora Inc. as Chief Operating Officer
      Denise Wocko Named Head of Global Client Portfolio Management at RQM+
      Contract Pharma

      Latest Breaking News From Contract Pharma

      MilliporeSigma Announces Proteologix as Winner of North American Biotech Grant
      Veeva Business Consulting Expands with New R&D Services
      Samsung Biologics Accelerates Timeline of New Fifth Plant
      Beauty Packaging

      Latest Breaking News From Beauty Packaging

      Estée Lauder Announces Second Edition of Beauty&You Brand Incubator Program
      GetHarley Raises $52 Million in Latest Funding Round
      Refillable Skincare Products Face Hurdles Despite Growing Sustainability Awareness
      Happi

      Latest Breaking News From Happi

      La Roche-Posay Expands Anti-Aging Collection with Niacinamide 10 Serum
      Rite Aid Launches Beauty and Personal Care Essentials Collection
      Proven Skincare Granted Second Personalization Patent
      Ink World

      Latest Breaking News From Ink World

      Siegwerk’s Center of Excellence in France Receives Facelift
      Epson announces MakeTheSwitch Campaign
      Pigments Market to Reach $26,598 Million by 2022: AMR
      Label & Narrow Web

      Latest Breaking News From Label & Narrow Web

      CCL to personalize online customer experience
      Michelman named recipient of IRI Excellence Award for Corporate Citizenship
      Registration opens for rebranded FTA Fall Technical Conference 2023
      Nonwovens Industry

      Latest Breaking News From Nonwovens Industry

      TechnoPlants to Exhibit at ITMA
      Andritz Buys 100% Stake in Dan-Web
      Luminy PLA Meets EU Sustainability Regulations
      Orthopedic Design & Technology

      Latest Breaking News From Orthopedic Design & Technology

      Orthobiologics Market to Top $10.3 Billion by 2030
      Artelon Granted U.S. FDA 510(k) Clearance for FlexBand, FlexPatch & FlexBand Plus
      Synergy Spine Solutions Completes Enrollment in IDE Clinical Trial
      Printed Electronics Now

      Latest Breaking News From Printed Electronics Now

      ASSA ABLOY Receives Clearance from Mexico for HHI Acquisition
      Christoph Ostermann Named Chairman of Heliatek‘s Advisory Board
      Flexible and Printed Electronics Represented at productronica 2023

      Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

      AD BLOCKER DETECTED

      Our website is made possible by displaying online advertisements to our visitors.
      Please consider supporting us by disabling your ad blocker.


      FREE SUBSCRIPTION Already a subscriber? Login